Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1400819
This article is part of the Research Topic Understanding Scleroderma: Symptoms, Causes, Treatment Options, and Advanced Diagnostic Techniques View all 3 articles

Integrin activating molecule-talin1 promotes skin fibrosis in systemic sclerosis

Provisionally accepted
Dan Xu Dan Xu Xiandun Yuan Xiandun Yuan *Zhaohua Li Zhaohua Li Rong Mu Rong Mu *
  • Department of Rheumatology, Peking University Third Hospital, Beijing, Beijing, China

The final, formatted version of the article will be published soon.

    Background: Integrin-dependent cell adhesion and migration play important roles in systemic sclerosis (SSc). The roles of integrin activating molecules including talins and kindlins, however, is unclear in SSc.We aimed to explore the function of integrin activating molecules in SSc.Methods: Transcriptome analysis of skin datasets of SSc patients was performed to explore the function of integrin-activating molecules including talin1, talin2, kindlin1, kindlin2 and kindlin3 in SSc. Expression of talin1 in skin tissue was assessed by multiplex immunohistochemistry staining. Levels of talin1 in serum were determined by ELISA. The effects of talin1 inhibition were analyzed in human dermal fibroblasts by real-time PCR, western blot and flow cytometry.We identified that talin1 appeared to be the primary integrin activating molecule involved in skin fibrosis of SSc. Talin1 was significantly upregulated and positively correlates with the modified Rodnan skin thickness score (mRSS) and the expression of pro-fibrotic biomarkers in the skin lesions of SSc patients. Further analyses revealed that talin1 is predominantly expressed in the dermal fibroblasts of SSc skin and promotes fibroblast activation and collagen production. Additionally, talin1 primarily exerts its effects through integrin β1 and β5 in SSc.Conclusions: Overexpressed talin1 is participated in skin fibrosis of SSc, and talin1 appears to be a potential new therapeutic target for SSc.

    Keywords: systemic sclerosis, Fibrosis, integrin activating molecules, Talin1, integrin

    Received: 14 Mar 2024; Accepted: 07 May 2024.

    Copyright: © 2024 Xu, Yuan, Li and Mu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Xiandun Yuan, Department of Rheumatology, Peking University Third Hospital, Beijing, Beijing, China
    Rong Mu, Department of Rheumatology, Peking University Third Hospital, Beijing, Beijing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.